New research suggests that it could be possible to separate treatment from hallucinations when developing new drugs based on ...

UB neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication alleviates symptoms of major depression in as little as a few hours.

The origin of many diseases such as Alzheimer's or Parkinson's can be found at the molecular level in our body, in other ...